Bystander-Balance PhD Project: Join the Genome Stability group at King’s College London to explore the modulation of cell death in bystander cells, which can potentially enhance cancer therapy responses. This funded PhD project offers an annual stipend and the chance to work in a cutting-edge research environment.
Designation
PhD Student – Bystander-Balance: Modulating cell death in bystander cells to improve therapy response
Details
| Research Area | Location | Eligibility/Qualification |
|---|---|---|
| Biomedical and Life Sciences | King’s College London, UK | Open to Home fees status applicants. English language band: D. Meets Cancer and Pharmaceutical Science Research MPhil/PhD entry requirements. |
Description
The PhD project involves studying bystander apoptosis, where neighboring cells undergo apoptosis in response to dying cells, potentially boosting the effects of cancer therapies. The project is embedded in the Genome Stability group at King’s College London, School of Cancer & Pharmaceutical Sciences. Focused on understanding DNA damage repair mechanisms, you will engage in genetic screens and molecular biology techniques, such as whole genome CRISPR screens, to uncover the molecular mechanisms of cell-to-cell communication during bystander apoptosis. This research can improve therapeutic efficacy and minimize collateral damage during cancer treatment.
How to Apply
Interested candidates must contact Dr. Graeme Hewitt via email (graeme.hewitt@kcl.ac.uk) with their CV and a covering letter. Additionally, applicants must complete the KCL online application form and meet the entry requirements for the Cancer and Pharmaceutical Science Research MPhil/PhD (Full-time). Use the funding code: 2024_Bystander when applying through the King’s Apply portal.
Last Date for Apply
Until position filled
